Biologics Recon Biocomposites to host industry symposium and present new STIMULAN® data at EBJIS-MSIS 2026 byNoah SimmonsSeptember 9, 2026
Biologics Top Stories UK’s MHRA Accepts Biosplice’s Application for Lorecivivint (LOR) in Knee Osteoarthritis and Begins Assessment byNoah SimmonsSeptember 8, 2026
Biologics Spine Joseph Spine Institute Announces New Regenerative Therapy Center, Offering Advanced Adipose-Derived Cell and PRP Therapies byTim AllenSeptember 3, 2026
Biologics Hospitals Spine Top Stories INFUSE Bone Graft for TLIF receives eligibility for Medicare New Technology Add-on Payment, Advancing Reimbursement Support for Hospitals and Spine Surgeons byNoah SimmonsSeptember 2, 2026
Biologics Sports Medicine FibroBiologics Appoints Leigh Steinberg to Board of Directors byTim AllenAugust 24, 2026
Biologics Top Stories Sports Medicine Biologics Market Research Report 2026-2031: Demand for Faster Recovery and Reduced Downtime Drives Market Growth byNoah SimmonsAugust 19, 2026
Biologics BioLab Holdings Adds FastSkin®Autologous Wound Care Technology to Tissue Restoration Portfolio byNoah SimmonsAugust 19, 2026
Biologics FibroBiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair in Preclinical Study of Degenerative Joints byNoah SimmonsAugust 18, 2026
Biologics Financial Top Stories Isto Biologics strengthens its bone graft substitutes platform with the acquisition of NovaBone byTim AllenAugust 5, 2026